Can a high omega-6:omega-3 or AA:EPA ratio amplify allergic-type inflammation?

The ratio of dietary fatty acids significantly influences the biochemical environment of the body, particularly concerning the production of signaling molecules involved in inflammation and allergic responses.

Mechanistic basis of lipid mediator shifts

The balance between omega-6 and omega-3 fatty acids, and specifically the ratio of arachidonic acid (AA) to eicosapentaenoic acid (EPA), dictates which lipid mediators are synthesized. This shift is driven by competitive substrate inhibition:

• Enzymatic Competition: Both AA and EPA compete for the same cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. When the AA:EPA ratio is high, AA dominates these pathways, leading to the production of series-2 prostaglandins (like PGE2) and series-4 leukotrienes (like LTB4).
• Substrate Preference: While EPA can also be processed by these enzymes to produce less inflammatory series-3 prostaglandins and series-5 leukotrienes, a high intake of omega-6 fatty acids (like linoleic acid) typically inhibits the conversion of omega-3 precursors into EPA, further skewing the ratio toward AA-derived products.

Amplification of allergic signaling

AA-derived eicosanoids function as active orchestrators of the allergic-type inflammatory response, particularly through Type 2 (Th2) immune pathways:

• Cellular Recruitment: AA-derived mediators such as PGD2 and cysteinyl leukotrienes (cysLTs) act as potent chemoattractants, recruiting eosinophils, basophils, and Th2 cells to the site of inflammation.
• Cytokine Feed-forward Loops: These eicosanoids signal through specific receptors (like CRTH2 and CysLT1) on Th2 cells and innate lymphoid cells (ILC2s), stimulating the release of key allergic cytokines including IL-4, IL-5, and IL-13.
• Mast Cell Priming: Leukotrienes can prime mast cells to increase the production of TNF-α and IL-5 upon allergen exposure, creating a self-sustaining cycle of chronic allergic inflammation.

Bottom line

Strong biochemical and mechanistic evidence supports the claim that high omega-6:omega-3 and AA:EPA ratios promote the production of arachidonic acid-derived eicosanoids. These molecules directly amplify allergic-type signaling by recruiting inflammatory cells and stimulating Th2 cytokine production.